$243 Million is the total value of JW Asset Management, LLC's 8 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 80.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ESTA | ESTABLISHMENT LABS HLDGS INC | $209,586,640 | +20.2% | 3,192,485 | 0.0% | 86.23% | -3.8% | |
CPRX | New | CATALYST PHARMACEUTICALS INC | $10,479,091 | – | 563,392 | +100.0% | 4.31% | – |
CELH | Buy | CELSIUS HLDGS INC | $8,951,394 | +143.7% | 86,038 | +112.4% | 3.68% | +95.0% |
NVO | New | NOVO-NORDISK A Sadr | $6,022,630 | – | 44,500 | +100.0% | 2.48% | – |
HZNP | HORIZON THERAPEUTICS PUB L | $5,766,587 | +83.9% | 50,673 | 0.0% | 2.37% | +47.1% | |
IDAHO STRATEGIC RESOURCES | $1,237,761 | +20.1% | 217,151 | 0.0% | 0.51% | -4.0% | ||
MSAC | MEDICUS SCIENCES ACQUISITION | $1,007,000 | +1.7% | 100,000 | 0.0% | 0.41% | -18.7% | |
MSACW | MEDICUS SCIENCES ACQUISITION*w exp 02/12/202 | $1,000 | – | 11,110 | 0.0% | 0.00% | – | |
MSOS | Exit | ADVISORSHARES TRpure us cannabis | $0 | – | -59,913 | -100.0% | -0.28% | – |
HMCOU | Exit | HUMANCO ACQUISITION CORPunit 12/08/2023 | $0 | – | -85,000 | -100.0% | -0.44% | – |
Exit | QUIDELORTHO CORP | $0 | – | -15,868 | -100.0% | -0.58% | – | |
Exit | META PLATFORMS INCput | $0 | – | -30,000 | -100.0% | -2.09% | – | |
Exit | INVESCO QQQ TRput | $0 | – | -17,500 | -100.0% | -2.40% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-10
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
AMAZON COM INC COM | 30 | Q1 2022 | 44.1% |
ESTABLISHMENT LABS HLDGS INC | 21 | Q3 2023 | 92.3% |
ANTARES PHARMA INC | 19 | Q2 2019 | 4.0% |
EAGLE PHARMACEUTICALS INC | 18 | Q1 2019 | 28.4% |
HORIZON PHARMA PLC | 18 | Q1 2019 | 8.2% |
HORIZON THERAPEUTICS PUB LTD | 17 | Q2 2023 | 6.5% |
LIGAND PHARMACEUTICALS INC SHS CL B | 17 | Q4 2018 | 3.4% |
BIOSPECIFICS TECHNOLOGIES CO | 16 | Q1 2019 | 8.4% |
MICROSOFT CORP | 14 | Q1 2020 | 11.1% |
CAMBREX CORP COM | 14 | Q1 2018 | 2.6% |
View JW Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
ESTABLISHMENT LABS HOLDINGS INC. | May 30, 2019 | 2,320,364 | 11.4% |
EAGLE PHARMACEUTICALS, INC. | January 27, 2017 | 397,648 | 2.6% |
View JW Asset Management, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-09 |
4 | 2024-01-02 |
SC 13D/A | 2024-01-02 |
4 | 2023-12-26 |
4 | 2023-12-19 |
4 | 2023-12-12 |
4 | 2023-12-07 |
4 | 2023-12-06 |
4 | 2023-11-21 |
4 | 2023-11-20 |
View JW Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.